MX358504B - Lagrimas artificiales y usos terapeuticos. - Google Patents
Lagrimas artificiales y usos terapeuticos.Info
- Publication number
- MX358504B MX358504B MX2014012100A MX2014012100A MX358504B MX 358504 B MX358504 B MX 358504B MX 2014012100 A MX2014012100 A MX 2014012100A MX 2014012100 A MX2014012100 A MX 2014012100A MX 358504 B MX358504 B MX 358504B
- Authority
- MX
- Mexico
- Prior art keywords
- oil
- artificial tears
- therapeutic uses
- dog
- cat
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/55—Linaceae (Flax family), e.g. Linum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Ophthalmology & Optometry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
Abstract
La presente invención provee composiciones oftálmicas, v.gr., lágrimas artificiales, adecuadas para tratar síndrome de ojo seco en un humano u otro mamífero que padece el mismo, v.gr., un perro o gato, que comprende una mezcla de aceite de ricino con otro aceite, v.gr., un aceite alimenticio, v.gr., aceite de oliva, aceite de ajonjolí, aceite de maíz, etc.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18433909P | 2009-06-05 | 2009-06-05 | |
PCT/US2010/037153 WO2010141648A2 (en) | 2009-06-05 | 2010-06-03 | Artificial tears and therapeutic uses |
Publications (1)
Publication Number | Publication Date |
---|---|
MX358504B true MX358504B (es) | 2018-08-21 |
Family
ID=42312750
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2011013007A MX2011013007A (es) | 2009-06-05 | 2010-06-03 | Lagrimas artificiales y usos terapeuticos. |
MX2014012100A MX358504B (es) | 2009-06-05 | 2010-06-03 | Lagrimas artificiales y usos terapeuticos. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2011013007A MX2011013007A (es) | 2009-06-05 | 2010-06-03 | Lagrimas artificiales y usos terapeuticos. |
Country Status (24)
Country | Link |
---|---|
US (6) | US8496976B2 (es) |
EP (1) | EP2437762B1 (es) |
KR (1) | KR101778316B1 (es) |
CN (2) | CN102458430A (es) |
AU (1) | AU2010256652B2 (es) |
BR (1) | BRPI1011710B8 (es) |
CA (1) | CA2764802A1 (es) |
DK (1) | DK2437762T3 (es) |
ES (1) | ES2646338T3 (es) |
HK (1) | HK1214943A1 (es) |
HR (1) | HRP20171691T1 (es) |
HU (1) | HUE034213T2 (es) |
IL (1) | IL216800A (es) |
LT (1) | LT2437762T (es) |
MX (2) | MX2011013007A (es) |
MY (1) | MY172185A (es) |
NO (1) | NO2437762T3 (es) |
NZ (1) | NZ596932A (es) |
PL (1) | PL2437762T3 (es) |
PT (1) | PT2437762T (es) |
RU (1) | RU2589837C2 (es) |
SI (1) | SI2437762T1 (es) |
WO (1) | WO2010141648A2 (es) |
ZA (1) | ZA201108979B (es) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8569367B2 (en) | 2004-11-16 | 2013-10-29 | Allergan, Inc. | Ophthalmic compositions and methods for treating eyes |
MX2011013007A (es) | 2009-06-05 | 2012-02-28 | Allergan Inc | Lagrimas artificiales y usos terapeuticos. |
US8957048B2 (en) * | 2011-10-06 | 2015-02-17 | Allergan, Inc. | Compositions for the treatment of dry eye |
PL2787969T3 (pl) * | 2011-12-07 | 2021-12-20 | Allergan, Inc. | Skuteczne dostarczanie lipidów do ludzkiego filmu łzowego z zastosowaniem układu emulsji wrażliwej na sól |
US9907826B2 (en) | 2011-12-07 | 2018-03-06 | Allergan, Inc. | Efficient lipid delivery to human tear film using a salt-sensitive emulsion system |
US9278132B2 (en) * | 2012-02-13 | 2016-03-08 | Bausch & Lomb Incorporated | Ophthalmic pharmaceutical compositions and methods of making and using same |
TWI659737B (zh) * | 2012-03-30 | 2019-05-21 | 布萊恩霍頓視力協會 | 用於降低眼部不適的方法及組成物 |
US9289494B2 (en) * | 2013-11-20 | 2016-03-22 | RestorTears, LLC | Method of treating ocular disorders with compounds found in Harderian gland secretions |
EP3182985B1 (en) | 2014-08-20 | 2020-01-08 | Silk Technologies Ltd. | Fibroin-derived protein composition |
US10279005B2 (en) * | 2014-11-25 | 2019-05-07 | Allergan, Inc. | Stabilized omega-3 ophthalmic compositions |
WO2017066429A1 (en) | 2015-10-14 | 2017-04-20 | Paul Gavaris | Ophthalmic treatment composition and vehicle for delivery of pharmaceutical substances or therapeutic agents |
US10953132B2 (en) | 2016-04-08 | 2021-03-23 | Cornell University | Method to enhance wound healing using silk-derived protein |
PL3266446T3 (pl) | 2016-07-07 | 2019-05-31 | Salvat Lab Sa | Kompozycja oftalmiczna zawierająca olej rycynowy i trójgliceryd o średniej długości łańcucha |
SG11201901137UA (en) | 2016-08-12 | 2019-03-28 | Silk Technologies Ltd | Silk-derived protein for treating inflammation |
WO2018035469A1 (en) * | 2016-08-19 | 2018-02-22 | Akrivista, LLC | Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eye |
GB201618175D0 (en) * | 2016-10-27 | 2016-12-14 | Warneford Healthcare Ltd | Pharmaceutical compositions |
GB2606486B (en) * | 2017-06-30 | 2023-03-22 | Jenivision Inc | Formulations for relieving dry eye |
CN111295169A (zh) | 2017-08-18 | 2020-06-16 | 阿克里维斯塔有限责任公司 | 诊断和治疗干眼综合症的方法和用于治疗人类眼睛的组合物 |
US10966948B2 (en) | 2019-07-23 | 2021-04-06 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
US11197841B2 (en) | 2019-07-23 | 2021-12-14 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
EP3829566A2 (en) | 2018-07-27 | 2021-06-09 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
WO2020021481A1 (en) | 2018-07-27 | 2020-01-30 | Johnson & Johnson Vision Care, Inc. | Compositions and methods for treating the eye |
US11166997B2 (en) | 2018-07-27 | 2021-11-09 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
AU2019311849B2 (en) | 2018-07-27 | 2023-06-08 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
BR112021001092A2 (pt) | 2018-07-27 | 2021-04-20 | Johnson & Johnson Surgical Vision, Inc. | composições e métodos para tratar os olhos |
US11110051B2 (en) | 2018-08-30 | 2021-09-07 | Johnson & Johnson Consumer Inc. | Topical compositions comprising Pichia anomala and n-acetyl glucosamine |
US11045416B2 (en) | 2018-08-30 | 2021-06-29 | Johnson & Johnson Consumer Inc. | Topical compositions comprising Pichia anomala and retinol |
KR20210009947A (ko) | 2019-07-18 | 2021-01-27 | 윤영선 | 산소가 도입된 점안제, 및 그 제조방법 |
EP3824877A1 (en) | 2019-11-19 | 2021-05-26 | Johnson & Johnson Consumer Inc. | Compositions and methods for treating the eye |
CN112823789B (zh) | 2019-11-19 | 2024-05-10 | 强生外科视力公司 | 用于治疗眼睛的组合物和方法 |
US11969454B2 (en) | 2019-11-19 | 2024-04-30 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
US11969451B2 (en) | 2019-11-19 | 2024-04-30 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
EP4059508A1 (en) | 2021-03-19 | 2022-09-21 | Johnson & Johnson Consumer Inc. | Methods of using compositions comprising an iceland moss extract |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56104814A (en) * | 1980-01-25 | 1981-08-20 | Kunihiro Okanoe | Preparation of eye drop |
US4649047A (en) | 1985-03-19 | 1987-03-10 | University Of Georgia Research Foundation, Inc. | Ophthalmic treatment by topical administration of cyclosporin |
DE3851152T2 (de) | 1987-09-03 | 1995-01-26 | Univ Georgia | Cyclosporin-augenmittel. |
US4839342A (en) | 1987-09-03 | 1989-06-13 | University Of Georgia Research Foundation, Inc. | Method of increasing tear production by topical administration of cyclosporin |
FR2638089A1 (fr) * | 1988-10-26 | 1990-04-27 | Sandoz Sa | Nouvelles compositions ophtalmiques a base d'une cyclosporine |
US5474979A (en) * | 1994-05-17 | 1995-12-12 | Allergan, Inc. | Nonirritating emulsions for sensitive tissue |
WO1997024129A1 (en) | 1995-12-27 | 1997-07-10 | Rohto Pharmaceutical Co., Ltd. | Pharmaceutical composition containing trehalose |
US5981607A (en) | 1998-01-20 | 1999-11-09 | Allergan | Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers |
GB0012597D0 (en) | 2000-05-25 | 2000-07-12 | Astrazeneca Ab | Formulation |
US7027446B2 (en) | 2001-07-18 | 2006-04-11 | P-Cube Ltd. | Method and apparatus for set intersection rule matching |
JP4284491B2 (ja) | 2002-07-16 | 2009-06-24 | 豊和工業株式会社 | ピストン外形の加工データ生成装置 |
UY28126A1 (es) * | 2002-12-24 | 2004-06-30 | Alcon Inc | Uso de glucocorticoides selectivos para la superficie ocular en el tratamiento de la sequedad ocular |
EP2343045A3 (en) * | 2003-02-24 | 2011-09-21 | Pharmaceutical Productions Inc. | Transmucosal drug delivery system |
US20040185068A1 (en) | 2003-03-18 | 2004-09-23 | Zhi-Jian Yu | Self-emulsifying compositions, methods of use and preparation |
US20060251685A1 (en) | 2003-03-18 | 2006-11-09 | Zhi-Jian Yu | Stable ophthalmic oil-in-water emulsions with Omega-3 fatty acids for alleviating dry eye |
CA2572344A1 (en) | 2004-07-01 | 2006-01-19 | Schepens Eye Research | Compositions and methods for treating eye disorders and conditions |
KR20070061537A (ko) * | 2004-08-27 | 2007-06-13 | 센주 세이야꾸 가부시키가이샤 | 건성안 치료용 안약액 |
US8569367B2 (en) * | 2004-11-16 | 2013-10-29 | Allergan, Inc. | Ophthalmic compositions and methods for treating eyes |
CN100562340C (zh) * | 2005-06-17 | 2009-11-25 | 中国科学院上海药物研究所 | 一种微乳型人工泪液 |
US7288520B2 (en) | 2005-07-13 | 2007-10-30 | Allergan, Inc. | Cyclosporin compositions |
US7297679B2 (en) | 2005-07-13 | 2007-11-20 | Allergan, Inc. | Cyclosporin compositions |
US7202209B2 (en) | 2005-07-13 | 2007-04-10 | Allergan, Inc. | Cyclosporin compositions |
WO2008035246A2 (en) | 2006-07-28 | 2008-03-27 | Novagali Pharma Sa | Compositions containing quaternary ammonium compounds |
WO2008027341A2 (en) | 2006-08-30 | 2008-03-06 | Merck & Co., Inc. | Topical ophthalmic formulations |
CN101668511A (zh) * | 2007-02-28 | 2010-03-10 | 阿西克斯医疗公司 | 正常化睑板腺分泌的方法和化合物 |
CN101554369B (zh) * | 2008-05-12 | 2012-07-25 | 陈亚玲 | 一种外用复合油纳米乳喷雾剂和滴眼剂及其制备方法 |
UA36915U (uk) * | 2008-05-28 | 2008-11-10 | Львівський Національний Медичний Університет Ім. Данила Галицького | Очні краплі для лікування запальних захворювань судинної оболонки та сухого кератокон'юнктивіту, які викликані аутоімунними процесами |
IT1393419B1 (it) | 2009-03-19 | 2012-04-20 | Medivis S R L | Composizioni oftalmiche a base di acidi grassi polinsaturi omega-3 e omega-6. |
US9480645B2 (en) | 2009-06-02 | 2016-11-01 | Abbott Medical Optics Inc. | Omega-3 oil containing ophthalmic emulsions |
MX2011013007A (es) | 2009-06-05 | 2012-02-28 | Allergan Inc | Lagrimas artificiales y usos terapeuticos. |
-
2010
- 2010-06-03 MX MX2011013007A patent/MX2011013007A/es active IP Right Grant
- 2010-06-03 CN CN2010800348429A patent/CN102458430A/zh active Pending
- 2010-06-03 HU HUE10724631A patent/HUE034213T2/en unknown
- 2010-06-03 DK DK10724631.6T patent/DK2437762T3/da active
- 2010-06-03 BR BRPI1011710A patent/BRPI1011710B8/pt active IP Right Grant
- 2010-06-03 AU AU2010256652A patent/AU2010256652B2/en active Active
- 2010-06-03 NZ NZ596932A patent/NZ596932A/en unknown
- 2010-06-03 WO PCT/US2010/037153 patent/WO2010141648A2/en active Application Filing
- 2010-06-03 KR KR1020127000233A patent/KR101778316B1/ko active IP Right Grant
- 2010-06-03 PT PT107246316T patent/PT2437762T/pt unknown
- 2010-06-03 MY MYPI2012000497A patent/MY172185A/en unknown
- 2010-06-03 SI SI201031575T patent/SI2437762T1/en unknown
- 2010-06-03 MX MX2014012100A patent/MX358504B/es unknown
- 2010-06-03 CN CN201510225116.XA patent/CN104906170A/zh active Pending
- 2010-06-03 RU RU2011151468/15A patent/RU2589837C2/ru active
- 2010-06-03 NO NO10724631A patent/NO2437762T3/no unknown
- 2010-06-03 EP EP10724631.6A patent/EP2437762B1/en not_active Revoked
- 2010-06-03 PL PL10724631T patent/PL2437762T3/pl unknown
- 2010-06-03 LT LTEP10724631.6T patent/LT2437762T/lt unknown
- 2010-06-03 CA CA2764802A patent/CA2764802A1/en not_active Abandoned
- 2010-06-03 US US13/376,374 patent/US8496976B2/en active Active
- 2010-06-03 ES ES10724631.6T patent/ES2646338T3/es active Active
-
2011
- 2011-12-06 IL IL216800A patent/IL216800A/en active IP Right Grant
- 2011-12-07 ZA ZA2011/08979A patent/ZA201108979B/en unknown
-
2013
- 2013-06-28 US US13/931,281 patent/US8679554B2/en active Active
-
2014
- 2014-01-28 US US14/166,589 patent/US9821020B2/en active Active
-
2016
- 2016-03-14 HK HK16102876.7A patent/HK1214943A1/zh unknown
-
2017
- 2017-10-23 US US15/791,158 patent/US11045515B2/en active Active
- 2017-11-06 HR HRP20171691TT patent/HRP20171691T1/hr unknown
-
2021
- 2021-05-25 US US17/329,586 patent/US20220008496A1/en not_active Abandoned
-
2023
- 2023-08-03 US US18/364,692 patent/US20240108677A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY172185A (en) | Artificial tears and therapeutic uses | |
PH12020550450A1 (en) | Certain chemical entities, compositions and methods | |
MY169328A (en) | Compositions for the treatment of dry eye | |
MY173616A (en) | Compositions and methods for lowering triglycerides | |
MX2010003117A (es) | Compuestos y composiciones como moduladores de la actividad de gpr119. | |
MX2009009491A (es) | Compuestos y composiciones como moduladores de la actividad del gpr119. | |
WO2012024620A3 (en) | Autotaxin inhibitors and uses thereof | |
CO6571886A2 (es) | Antagonistas de pcsk9 | |
WO2010083239A3 (en) | Therapeutic modulation of vaginal epithelium boundary lubrication | |
EA201290498A1 (ru) | Терапевтические полимерные наночастицы, включающие эпотилон, и способы их получения и применения | |
IN2012DN02469A (es) | ||
WO2011019822A3 (en) | Compositions and methods for implantation of processed adipose tissue and processed adipose tissue products | |
MY171920A (en) | Prevention and treatment of ocular conditions | |
EA201790267A1 (ru) | Новые модуляторы киназ | |
PL2262476T3 (pl) | Dostarczanie leku do przedniego i tylnego odcinka oka z użyciem kropli do oczu | |
ATE456369T1 (de) | Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen | |
MX2011013060A (es) | Formulaciones oftalmicas, metodos de preparacion y metodos para utilizarlas. | |
WO2009089635A9 (en) | Treating neurodegenerative diseases with progranulin (pgrn) | |
IN2012DN00624A (es) | ||
MX2012004078A (es) | Compuestos y composiciones como moduladores de la actividad de gpr119. | |
WO2010121164A3 (en) | 1,4-benzodiazepinone compounds and their use in treating cancer | |
EP2438923A4 (en) | COMPOSITION FOR THE PREVENTION OR TREATMENT OF OBESITY-RELATED DISORDERS MEDIATED BY AMPK ACTIVATION AND THE ACTIVE INGREDIENTS OF WHICH HAVE 2,5-BIS-ARYL-3,4-DIMETHYLTETRAHYDROFURAN LIGNANS | |
BR112014000634A2 (pt) | métodos para tratamento de incontinência associada com atividade sexual | |
MX2013004062A (es) | Analogos de ciclosporina. | |
UY33153A (es) | Formulación tópica oftálmica de péptidos |